Skip to main content
SpringerLink
Log in

Krummer Penis macht Sex zur Qual

Morbus Peyronie

  • FORTBILDUNG
  • SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Eine Penisverkrümmung und Schmerzen bei der Erektion sind die Folgen des Morbus Peyronie. Es handelt sich dabei um eine Fibromatose der Tunica albuginea des Penis, die über eine zunehmende Plaquebildung die genannten Symptome verursachen kann. Betroffene Männer wenden sich oft zunächst an den Hausarzt. Genaues Hinschauen ist also gefragt!

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur (bitte daneben stellen)

  1. De La Peyronie F. Sur Quelques obstacles qui soppoent a lejaculation naturelle de la semance. Med Aca R Chir 1743;1:425.

    Google Scholar 

  2. Ralph D, et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med 2010;7:2359–74.

    Article  PubMed  Google Scholar 

  3. Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie’s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol 2010;7(4):215–21.

    Article  PubMed  CAS  Google Scholar 

  4. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int 2001;88:727–30.

    Article  PubMed  CAS  Google Scholar 

  5. Mulhall JP, Creecj SD, Bpprijan SA et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350–3.

    Article  PubMed  Google Scholar 

  6. Kadioglu A, Oktar T, Kandirali E, et al. Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 2004;16:540–3.

    Article  PubMed  CAS  Google Scholar 

  7. Dibinedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie’s disease: prevalence and treatment patterns in the United States. Adv Urol 2011;2011:28503.

    Google Scholar 

  8. Tal R, Hall MS, Alex B, Choi J, Mulhall JP. Peyronie’s disease in teenagers. J Sex Med 2012;9(1):302–8.

    Article  PubMed  Google Scholar 

  9. Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie’s and Dupuytren’s disease. Int J Impot Res 2011;23(4):142–5.

    Article  PubMed  CAS  Google Scholar 

  10. Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G. A cross-sectional study for the analysis of clinical, sexual and laboratory conditions to Peyronie’s disease. J Sex Med 2010;7(4 Pt 1):1529–37.

    Article  PubMed  Google Scholar 

  11. Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF. Comparison of gene expression profiles between Peyronie’s disease and Dupuytren’s contracture. Urology 2004;64(2):399–404.

    Article  PubMed  CAS  Google Scholar 

  12. Klotz T, Mathers MJ, Sommer F. Induratio penis plastica-eine verschwiegene Erkrankung. Dtsch Arztebl 2007;104(5):A 263–7.

    Google Scholar 

  13. Usta MF, Bivalacque TJ, Jabren GW, et al. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie’s disease. J Urol 2004;171:775–9.

    Article  PubMed  Google Scholar 

  14. Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: etiology, medical and surgical therapy. J Androl 2000;21:347–54.

    PubMed  CAS  Google Scholar 

  15. Pryor JP, Ralph DJ. Clinical presentations of Peyronie’s disease. Int J Impot Res 2002;14:414–7.

    Article  PubMed  CAS  Google Scholar 

  16. Shabsigh R, Fleming M, Pereman M, Anastasiadis A. Peyronie’s disease index (PDI):a standardized patients questionaire. Int J Impot Res 2003;14(Suppl 5):568.

    Google Scholar 

  17. Larsen SM, Levine LA. Review of non-surgical treatment options for Peyronie’s disease. Int J Impot Res 2012;24(1):1–10.

    Article  PubMed  CAS  Google Scholar 

  18. Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized study. Int J Impot Res 2010;22(5):298–309.

    Article  PubMed  CAS  Google Scholar 

  19. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int 2001;88(1):63–7.

    Article  PubMed  CAS  Google Scholar 

  20. Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol 2009;56(2):363–9.

    Article  PubMed  Google Scholar 

  21. De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results. Arch Ital Urol Androl 2010;82(2):128–33.

    PubMed  Google Scholar 

  22. Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl 2011 Nov 15.

  23. Mulhall JP, Anderson MS, Lubrano T, Shankey TV. Peyronie’s disease cell culture models: phenotypic, genotypic and functional analyses. Int J Impot Res 2002;14(5):397–405.

    Article  PubMed  CAS  Google Scholar 

  24. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol 2002;168(2):621–5.

    Article  PubMed  CAS  Google Scholar 

  25. Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie’s disease. Urology 2007;69(6):1181–4.

    Article  PubMed  Google Scholar 

  26. Moskovic DJ, Alex B, Choi JM, Nelson CJ, Mulhall JP. Defining predictors of presponse to intralesional verapamil injection therapy for Peyronie’s disease. BJU Int 2011;108(9):1485–9.

    Article  PubMed  CAS  Google Scholar 

  27. Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochiai A, Naitoh Y, Fujwara T, Kamoi K, Miki T. Nicardipine vs. saline injection as treatment for Peyronie’s disease: a prospective, randomized, single-blind trial. J Sex Med 2010;7(11):3743–9.

    Article  PubMed  CAS  Google Scholar 

  28. Gelbard MK, Lindner A, Kaufman JJ. The use of collagenase in the treatment of Peyronie’s disease. J Urol 1985;124(2):280–3.

    Google Scholar 

  29. Gelbard MK, James K, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie’s disease: a double-blind study. J Urol 1993;149(1):56–8.

    PubMed  CAS  Google Scholar 

  30. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: a prospective, single-center, non-placebo-controlled study. J Sex Med 2008;5(1):180–7.

    Article  PubMed  Google Scholar 

  31. Hauck EW, Diemer T, Weidner W. Induratio penis plastica. Urologe 2006;45:243–59.

    Article  Google Scholar 

  32. Serefoglu EC, Hellstrom WJ. Treatment of Peyronie’s disease: 2012 update. Curr Urol Rep 2011;12(6):444–52. Plastische, Hand- und Wiederherstellungschirurgie, Med. Hochschule Hannover

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heiligerstr. 3, D-30159, Hannover, Deutschland

    Karsten Knobloch (SportPraxis)

Authors
  1. Karsten Knobloch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karsten Knobloch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knobloch, K. Krummer Penis macht Sex zur Qual. MMW - Fortschritte der Medizin 154, 45–47 (2012). https://doi.org/10.1007/s15006-012-1343-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-012-1343-1

Keywords - Penis deviation with or without pain in Peyronie’s disease — an update

Search

Navigation